RecruitingNCT02838836

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers


Sponsor

University of Missouri-Columbia

Enrollment

620 participants

Start Date

Jul 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite surgery. Circulating and disseminated tumor cell (CTC/DTC) and circulating cell-free (cf) DNA isolation from the blood, urine and bone marrow will increase understanding of cancer spread and advance knowledge to develop individualized therapies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether cancer cells and cancer DNA shed from tumors can be detected in the blood, urine, and bone marrow of patients with various solid cancers, which could eventually lead to better and less invasive ways to detect and monitor cancer. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with a solid cancer such as lung, esophagus, stomach, bile duct or pancreas, colorectal, melanoma, or sarcoma at any stage - You are scheduled for surgery related to your cancer - You are of any gender or ethnicity **You may NOT be eligible if...** - You are not scheduled for surgical treatment - You have a blood cancer such as leukemia or lymphoma rather than a solid tumor Note: A small group of people without cancer who are having surgery for a non-cancerous reason may also be enrolled as a comparison group. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStudy sample collection

Blood draws, urine and tissue asservation, and bone marrow aspiration will be done during surgery


Locations(1)

Ellis Fischel Cancer Center, University of Missouri

Columbia, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02838836


Related Trials